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Background and aim of the study: Many variables
may affect the fluid dynamic of an implanted
bioprosthesis. In-vitro studies have provided
accurate data such that, when different prostheses
are implanted in the same true aortic root, it should
be possible to make a fair comparison. The study aim
was to evaluate the fluid dynamic and geometric
characteristics of the four most widely used stented
pericardial bioprostheses.
Methods: Four types of pericardial prosthesis (Magna
Ease 21, Trifecta 21, Soprano-Armonia 20, and
Mitroflow 23) that fitted eight aortic roots with a
native annulus diameter of 2.1 cm were implanted
and tested in a mock loop.
Results: Energy loss and mean gradients were
increased with stroke volume (SV) in all valves
tested. The effective orifice area values were 
fairly stable across the SV intervals (p = 0.57). 
All hemodynamic-related indices displayed
mutually consistent behaviors, with Trifecta showing
the lowest hindrance to flow. Both geometric orifice
area (GOA) and edge geometric orifice area (eGOA)
were increased significantly as the SV increased; the
Trifecta valve showed the largest eGOA value, while
the Trifecta and Mitroflow provided the largest
GOAs. For the Trifecta and Soprano-Armonia
prostheses (and the Magna to a lesser extent), the 
most distal cross-section was systematically greater
than the inflow area, suggesting a divergent
configuration at the systolic peak.
Conclusion: The study results combined the fluid
dynamic reproducibility of the in-vitro setting and
the specificity of surgery. A quantitative comparison
of the fluid dynamic performance of the different
bioprostheses was feasible.
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After aortic valve replacement, patients with small
aortic annuli are at risk of high transprosthesis
gradients (1,2). As these place an extra load on the left
ventricle, they may have a negative impact on the
patients’ survival and quality of life (3-7). In order to
implant a prosthesis that fits the patient’s
hemodynamic requirements and overcomes the
inherent obstruction due to the stent, both the
implantation of stentless valves and annulus
enlargement have been proposed, but the results
obtained have been disappointing (8,9). Pericardial
stented bioprostheses have displayed excellent
durability and yielded better fluid dynamic
performance than porcine prostheses, especially in
small aortic roots (10,11).
Prostheses differ both in design and in their true
dimensions, such as internal diameter (ID), tissue
annulus diameter (TAD) and external diameter (ED)
(12,13). This heterogeneity, along with the variability
of the aortic root anatomy (14), makes it difficult to
make a fair comparison of the hemodynamic
performance of the various prostheses. In evaluating
fluid dynamics, the in-vitro setting is the “gold
standard”, based on the high accuracy of its
measurements. However, a prosthesis needs to be
sutured in an aortic root that has specific anatomic
characteristics, which may in turn influence the
hemodynamic result. To eliminate the bias related to
anatomic variability, different prostheses should be
implanted in the same aortic root.
The aim of the present study was to evaluate any
differences in the fluid dynamic and geometric
characteristics of the four most widely used stented
pericardial bioprostheses, namely the Mitroflow and
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Soprano-Armonia (Sorin Group, Saluggia, Italy), the
Magna Ease (Edwards Lifesciences, Irvine, CA, USA)
and the Trifecta (St. Jude Medical, St. Paul, MN, USA),
at different values of stroke volume (SV). Prostheses
with labeled sizes that fitted porcine aortic roots with
a native aortic annulus of 2.1 cm in diameter were
selected and surgically implanted.
Materials and methods
ForCardio.Lab pulsatile mock loop
The ForCardio.Lab mock loop (15-17) is a computer-
controlled volumetric pump able to replicate left
ventricular flow waveforms; its test section is designed
to house a whole aortic root unit (ARU) and it is
equipped with an adjustable hydraulic. For this
experimental campaign, the mock loop was equipped
with a transit-time flow-meter (HT100R; Transonic
System Inc., Ithaca, NY, USA), the 1ʺ probe of which
was placed downstream of the ARU sample, and with
three pressure transducers (PC140 series; Honeywell
Inc., Morristown, NJ, USA). One pressure transducer
was placed immediately upstream and one
immediately downstream of the sample, and the third
was placed at the inlet section of the hydraulic
afterload part. A high-speed digital camera set at 1000
frames per second (Phantom Miro2; Vision Research,
Morristown, NJ, USA) was placed downstream of the
sample so as to acquire an aortic view of the working
prostheses. Hydrodynamic data were acquired via an
analog/digital (A/D) board (USB 6210; National
Instruments, Austin, TX, USA).
Sample preparation and prosthesis sizing
Eight fresh whole swine hearts, with a native aortic
annulus of 2.1 cm, were selected. Prosthesis sizing was
performed by using the probes and the valve replica
provided by the manufacturer for each prosthesis on
the eight hearts, to select the prosthesis that fitted the
annulus. The Trifecta (TRI) and Magna Ease (MG)
probes that fitted had the label size of 21. For
Mitroflow (MF), sizing was undertaken with the valve
replica alone, as this is the only tool provided by the
manufacturer, and a labeled size 23 was chosen. These
three valves - the TRI, MG and MF - have the same ED
(2.6 cm). For the Soprano-Armonia (SA) valve,
although the probe for the size labeled 22 was able
pass through the native annulus, the valve replica
appeared too bulky; thus, a size 20 was chosen. 
The ARU samples were then harvested by including
1.5 cm of the left ventricular outflow tract (LVOT),
which was rendered cylindrical by suturing the
anterior mitral valve leaflet to the adjacent muscular
septum. The ascending aorta was transected 0.5 cm
above the sinotubular junction (STJ) and the coronary
ostia were ligated. Circular Dacron meshes were
sutured to the inflow and outflow to fix the aortic root
samples into the housing section of the mock loop 
(15-17).
Experimental design
Tests were conducted at SV-values of 30 ml, 50 ml, 65
ml, and 85 ml. The systolic ejection time was set at one-
third of the entire cardiac cycle, and the heart rate at 70
bpm, with a mean simulated arterial pressure of 80-104
mmHg. After housing each ARU sample in the test-
section holder, the four bioprostheses were implanted
in a randomized sequence. For each experimental
point, data were evaluated over five consecutive
simulated heart cycles.
The prostheses were implanted by means of a simple
interrupted suture technique with ethylene
terephthalate sutures (Ethibond 2/0). The flow rate,
the pressures upstream and downstream of the aortic
root, and the pressure in the afterload were acquired at
a sampling rate of 200 Hz via an A/D acquisition
board. Post-processing of the raw data was performed
to calculate the following quantities:
• The mean systolic pressure drop (Δpm, in mmHg)
across the aortic root unit (i.e., the difference
between pressures measured immediately
upstream and downstream of the ARU) and
averaged over the systolic interval.
• The effective orifice area (EOA, in cm2) was
calculated from the formula:
where Qrms (l/min) is the square-root of the mean
systolic flow rate, Δpm (in mmHg) is the mean systolic
pressure drop across the sample, and k is a conversion
factor (k = 3.1 to yield the EOA in cm2).
• The geometric orifice area (GOA, in cm2) was
evaluated semi-quantitatively by means of high-
speed videos as the largest cross-section opening
area recorded during systole.
• The edge geometric orifice area (eGOA, in cm2)
was evaluated semi-quantitatively from the high-
speed videos by tracking the free edges of the
prostheses’ leaflets at the systolic peak, and
integrating the resulting area.
• Space efficiency = the ratio between GOA and the
area calculated from the external diameter of the
prosthesis.
• Performance index (Pi) = EOA/inner GOA. 
The inner GOA was calculated from the ID values
provided by the manufacturers: TRI = 1.83 cm; 
MF = 1.9 cm; SA = 1.98 cm; MG = 2.0 cm.
EOA(cm2) = 
Qrms
p    k   6   m3
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• Systolic energy loss: this is the energy provided by
the pump that is lost when the fluid passes
through the prosthesis, expressed in Joules (J).
• Systolic energy loss (%): this is the percentage of
the energy provided by the pump that is lost
when the fluid passes through the prosthesis.
• Coefficient of contraction (Cc) = EOA/GOA.
• Geometric area ratio = GOA/inner GOA. The
inner GOA is calculated from the internal
diameter of the prosthesis.
GOA and eGOA were evaluated from high-speed
videos by means of a semi-automated tracking
algorithm developed in Matlab (MathWorks Inc., MA,
USA) (18).
Statistical analysis
Continuous variables were expressed as mean ± SD
and compared by means of ANOVA for repeated
measures, with Bonferroni’s test used in post-hoc
analysis; in the graph, the values are reported with
95% confidence intervals; a p-value <0.05 was
considered statistically significant. The data were
analyzed by means of Statsoft 8.2 software.
Results
None of the valves displayed any significant
structural problems in any of the test sessions, the
results of which are listed in Table I. Energy loss and
mean pressure gradients (Fig. 1) were increased with
SV in all valves tested, with TRI displaying a lower
level of significance than the other prostheses. EOA
values were fairly stable across the SV intervals 
(p = 0.57); once again, TRI showed the largest value
(Table I; Fig. 2). Similar considerations are applicable
for the Pi (the ratio between the EOA and inner GOA).
The eGOA was increased significantly as the SV
increased, with TRI providing the largest value 
(Table I; Fig. 3). The GOA was also increased
significantly on increasing the SV, with TRI and MF
providing the largest areas (Table I; Fig. 3). For the TRI
and SA prostheses (and for MG to a lesser extent), the
most distal cross-section was systematically greater
than in the other prostheses, which suggests a
divergent configuration at the systolic peak.
Figure 1: Relationship between (a) mean pressure drops and (b) energy loss with stroke volume (SV). Bars represent 95%
confidence intervals. The rectangle represents the physiologic SV interval at rest in patients whose body size matches the sizes
of the prostheses.
Figure 2: Relationship between effective orifice area (EOA)
and stroke volume (SV). Bars represent 95% confidence
intervals. The rectangle represents the physiologic SV
interval at rest in patients whose body size matches the
sizes of the prostheses.
a b
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Discussion
Bioprostheses are the most frequently implanted
valves. Among those currently in use, pericardial
stented valves have shown better fluid dynamic
results than porcine valves, especially in patients with
small aortic annuli (10,11,19). Although durability is
the main concern, the fluid dynamic performance of a
bioprosthesis cannot be neglected because the residual
obstruction places an extra load on the left ventricle,
with detrimental effects (3-7). However, despite
substantial improvements the performance of stented
bioprostheses is far from that of a native valve (20).
Theoretical aspects
Interaction between the prosthesis and flow is
mainly subjected to the concentrated loss of head laws.
The quantity of the mechanical energy dissipated
correlates well, after pressure recovery has taken
place, with the pressure drop across the orifice (21,22)
with a quadratic relationship with flow. Pressure drop,
for a certain flow, depends on the prosthesis structural
characteristics (stent design and material used),
geometric properties (ID and GOA projected by the
leaflets), and both inflow (LVOT/prosthesis) and
outflow (prosthesis/STJ) characteristics (23). The
orifice provided to the flow by the bioprosthesis is the
result of an interaction between the inner GOA,
calculated from the ID being the theoretical largest
orifice available for the flow, and the projected GOA of
the leaflets when fully opened. The flow passing
through these two orifices contracts with its minimum
at the level of “vena contracta”. The EOA represents
the actual area used by the flow, and is the term on
which the pressure drop mainly depends. In contrast
to Doppler, the EOA, when calculated with an invasive
procedure or an in-vitro setting, is larger than the
“vena contracta” because it depends on the extent of
the pressure recovery (23).
Complexity of the clinical scenario
The clinical scenario is tremendously complex
because the patient’s anatomic and physiologic
conditions impact on postoperative valve fluid
dynamics. In addition, the implantation process hides
several pitfalls that affect the size of prosthesis to be
implanted, and is the main factor affecting fluid
dynamics. The prosthesis size implanted depends on
the manufacturer’s sizing strategy, surgical procedure,
and the patient’s aortic root characteristics. The
manufacturer’s sizing strategy is specific to each valve
brand, and implies that prostheses with different
labeled sizes, but made by different manufacturers,
may fit the same aortic root (12,14). The impact of the
surgical procedure depends on the surgeon’s aptitude
and experience, as well as the suture technique
adopted (24,25). Finally, the LVOT characteristics
(shape and size) and annulus-prosthesis interaction
may affect how smoothly/abruptly the flow lines
approach and enter into the prosthesis, while the size
of the STJ may also influence pressure recovery (23).
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Figure 3: Relationship between (a) geometric orifice area (GOA) and (b) edge geometric orifice area (eGOA) with stroke
volume (SV). Bars represent 95% confidence intervals. The rectangle represents the physiologic SV interval at rest in patients
whose body size matches the sizes of the prostheses.
a b
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Table I: Fluid dynamic and geometric results.
Variable Stroke volume Effect p-value
30 ml 50 ml 65 ml 85 ml
Mean gradient (mmHg)
MF 2.8 ± 0.64 5.8 ± 1.93 10.2 ± 2.67 15.2 ± 3.46 Valve <0.001
MG 3.2 ± 0.65 7.4 ± 2.51 13.2 ± 3.15 18.1 ± 4.16 Time (SV) <0.001
SA 2.0 ± 0.67 5.0 ± 1.57 9.6 ± 1.57 14.1 ± 1.34 Interaction <0.001
TRI 1.1 ± 0.58 2.9 ± 1.02 6.1 ± 1.93 9.2 ± 2.68
Energy loss (J)
MF 0.015 ± 0.01 0.05 ± 0.01 0.11 ± 0.03 0.22 ± 0.05 Valve <0.001
MG 0.018 ± 0.01 0.07 ± 0.02 016 ± 0.04 0.27 ± 0.07 Time (SV) <0.001
SA 0.010 ± 0.01 0.04 ± 0.01 0.11 ± 0.02 0.21 ± 0.04 Interaction <0.001
TRI 0.008 ± 0.01 0.03 ± 0.01 0.07 ± 0.02 0.14 ± 0.04
Energy loss (%)
MF 6.5 ± 1.42 8.7 ± 2.45 10.7 ± 2.51 13.3 ± 1.89 Valve <0.001
MG 7.3 ± 1.41 10.8 ± 3.78 13.5 ± 3.25 15.7 ± 2.81 Time (SV) <0.001
SA 4.6 ± 1.19 8.3 ± 2.72 10.9 ± 1.79 13.1 ± 1.38 Interaction <0.001
TRI 2.7 ± 1.23 4.3 ± 1.59 6.6 ± 1.63 8.4 ± 1.79
EOA (cm2)
MF 1.6 ± 0.22 1.8 ± 0.26 1.8 ± 0.21 1.8 ± 0.23 Valve <0.001
MG 1.5 ± 0.17 1.6 ± 0.26 1.6 ± 0.18 1.6 ± 0.20 Time (SV) 0.57
SA 1.9 ± 0.33 1.8 ± 0.42 1.7 ± 0.21 1.8 ± 9.20 Interaction 0.13
TRI 2.7 ± 0.48 2.6 ± 0.56 2.3 ± 0.34 2.4 ± 0.42
GOA (cm2)
MF 2.4 ± 0.05 2.7 ± 0.03 2.8 ± 0.05 2.9 ± 0.09 Valve <0.001
MG 2.0 ± 0.03 2.2 ± 0.03 2.3 ± 0.07 2.4 ± 0.05 Time (SV) <0.001
SA 1.7 ± 0.10 1.8 ± 0.07 1.9 ± 0.07 2.0 ± 0.05 Interaction <0.001
TRI 2.5 ± 0.06 2.7 ± 0.08 2.8 ± 0.02 2.9 ± 0.04
Edge GOA (cm2)
MF 2.42 ± 0.05 2.69 ± 0.03 2.81 ± 0.05 3.01 ± 0.05 Valve <0.001
MG 2.29 ± 0.07 2.42 ± 0.07 2.50 ± 0.09 2.78 ± 0.07 Time (SV) <0.001
SA 2.33 ± 0.08 2.42 ± 0.05 2.57 ± 0.08 2.83 ± 0.04 Interaction <0.001
TRI 3.16 ± 0.11 3.39 ± 0.11 3.62 ± 0.04 3.95 ± 0.19
Cc
MF 0.67 ± 0.10 0.62 ± 0.08 0.62 ± 0.10 0.58 ± 0.08 Valve <0.001
MG 0.75 ± 0.12 0.67 ± 0.10 0.65 ± 0.04 0.64 ± 0.07 Time (SV) <0.001
SA 1.07 ± 0.12 0.90 ± 0.18 0.85 ± 0.10 0.85 ± 0.10 Interaction 0.203
TRI 1.05 ± 0.22 0.92 ± 0.14 0.77 ± 0.11 0.76 ± 0.10
Performance index
MF 0.56 ± 0.08 0.62 ± 0.09 0.62 ± 0.08 0.63 ± 0.08 Valve <0.001
MG 0.49 ± 0.05 0.51 ± 0.08 0.50 ± 0.06 0.52 ± 0.06 Time (SV) 0.56
SA 0.61 ± 0.11 0.59 ± 0.14 0.57 ± 0.07 0.58 ± 0.07 Interaction 0.12
TRI 1.03 ± 0.18 0.98 ± 0.21 0.88 ± 0.13 0.90 ± 0.16
Space efficiency
MF 0.46 ± 0.01 0.51 ± 0.01 0.53 ± 0.01 0.55 ± 0.02 Valve <0.001
MG 0.38 ± 0.01 0.41 ± 0.01 0.43 ± 0.01 0.45 ± 0.01 Time (SV) <0.001
SA 0.30 ± 0.02 0.32 ± 0.01 0.34 ± 0.01 0.36 ± 0.01 Interaction <0.001
TRI 0.47 ± 0.01 0.51 ± 0.02 0.52 ± 0.01 0.55 ± 0.01
Geometric area ratio
MF 0.86 ± 0.02 0.95 ± 0.01 0.99 ± 0.02 1.04 ± 0.03 Valve <0.001
MG 0.65 ± 0.01 0.69 ± 0.01 0.72 ± 0.02 0.76 ± 0.02 Time (SV) <0.001
SA 0.56 ± 0.03 0.59 ± 0.02 0.63 ± 0.02 0.66 ± 0.02 Interaction <0.001
TRI 0.96 ± 0.02 1.02 ± 0.03 1.07 ± 0.01 1.10 ± 0.02
Values are mean ± SD.
Cc: Coefficient of contraction; EOA: Effective orifice area; GOA: Geometric orifice area.
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Interpretation of the in-vitro study
Fluid dynamic terms (energy loss, mean pressure drop and
EOA)
Mean pressure drops and energy losses were
increased on increasing the SV (Table I); these terms
displayed strongly non-linear trends, with different
patterns according to the bioprosthesis model (Fig. 1).
The TRI showed the best fluid dynamic behavior in
energetic terms and, accordingly, in terms of the EOA
(Fig. 2) than the MF, SA and MG. Moreover, at
physiologic SV values (i.e. >50 ml) the EOA values
were stable for all valve models, despite a statistically
significant increase in GOA. The trends of the mean
pressure drops for MF, MG and SA valves were
consistent with those obtained by Gerosa et al. (26) in
a fully artificial experimental set-up. Moreover, at
physiologic SV values the EOA values were stable for
all valve models, which suggests that for these
prostheses the interaction between the flow and the
valve structure is well exploited over this SV range.
Indeed, as the EOA is the result of hydrodynamic
measurements, it should be considered an index of
hydrodynamic performance, although at a first glance
it might be assimilated to a geometric parameter. 
The EOA of the SA valve was stable across the whole
SV range, while EOA values yielded by the TRI valve
were higher at SV <50 ml than at SV >50 ml. This can
be explained by the pliability of the leaflets, which are
probably completely open at low-flow regimens. 
In order to obtain an EOA that is characteristic of a
specific size and brand prosthesis type, the anatomy
upstream and downstream of the prosthesis must be
equal; this is easily achieved in vitro. Accordingly, the
fact that larger standard deviations of EOA were
found in the present study than by Gerosa et al. (27)
can be explained by the present use of eight different
ARUs, and the LVOTs and aortic roots which probably
had different morphologies. As the EOA value is
influenced by specific anatomic features in vivo, either
the application of Gorlin’s formula or the continuity
equation can yield only a partial view of the
performance of a specific type and size of prosthesis.
This makes the EOA value relevant only for those
patients in whom the prosthesis is being implanted,
and is much less relevant for the type and size 
of prosthesis.
Geometric terms (GOA, edge GOA, geometric area ratio,
space efficiency)
In all of the bioprostheses, both the GOA and eGOA
were increased as the SV increased, confirming that
pericardial stented valves have a reserve opening area
(19,27). At each SV level, the prostheses with
pericardial leaflets housed inside the stent (i.e. MG and
SA) showed smaller GOAs and eGOAs than both the
TRI and MF valves, in which the pericardium is
outside (Table I; Fig. 3). Interestingly, while the GOAs
of both TRI and MF valves were similar, the Cc proved
to be lower in MF valves (confirmed by a larger
pressure gradient drop and energy loss), indicating a
higher flow velocity due to certain, not immediately
apparent, structural characteristics. The shape
assumed by the prosthesis during the ejection period
played a role. Indeed, at 65 ml the TRI valve provided
both GOA and eGOA values larger than the inner
GOA, suggesting a divergent aperture, thus achieving
the lowest gradients and energy losses,
notwithstanding the smallest inner GOA. This shape
better exploited the inner GOA and might probably
determine less flow separation in the flow deceleration
zone, resulting in a greater energy recovery due to the
more gradual flow expansion and lower ratio between
eGOA and STJ diameter. The MF valve opened like a
cylinder, while the SA and MG valves showed a
convergent-divergent shape, having the eGOA smaller
than the inner GOA and larger than the GOA. This
peculiar morphology could be related to the internal
position of the pericardium.
Space efficiency (SE) was not related to the valve
performance. This was clear on comparing the MF and
TRI valves, which showed a similar SE, and also SA
and MG valves; indeed, while the SA valve had the
worst SE it performed better than the MG valve. It is
worth noting that ID size, when considering
prostheses that fit the same aortic root, is a parameter
that does not affect fluid dynamic and/or geometric
terms. Thus, a larger ID does not guarantee a larger
GOA or a lower pressure drop. What is most
important here is how much of this area is used by 
the flow.
Hybrid indexes (Cc and performance index)
In normally functioning bioprostheses, the Cc is
expected to be >0.9 (28), but this value was found only
in TRI and SA valves at SV values of 30 and 50 ml; as
the SV increased, the Cc was decreased. This can be
explained by the presence of the true LVOT that
influences how sharply/smoothly the flow lines
approach and enter into the prosthesis due to the
LVOT characteristics and aortic annulus-prosthesis
interaction. By contrast Pi, which describes a type of
“dynamic” efficiency, seems to be fairly well related to
the energy loss %. The performance appears to be
specific to each valve because they differ in terms of
the material used, stent design, and dimensions. The Pi
showed that the TRI valve made the best use of the
small area available. The MF valve also had a better Pi,
notably because of the position of the pericardium
outside the stent (as with the TRI valve).
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Study limitations
Although all conditions to which the prostheses
were exposed in the study were equal, the
“implantability” characteristics of each bioprosthesis,
along with the surgeon’s level of experience in
implanting a specific type of prosthesis, might have
influenced the results. However, such biases are
difficult to avoid, as they are specific to the surgical
procedure. The GOA and eGOA were evaluated from
a two-dimensional video, which implies that their
values are planar projections of a three-dimensional
area, and could be affected by experimental errors due
to misalignment between the evaluation plane and the
charge-coupled device sensor.
In conclusion, the study results confirmed that
pericardial stented prostheses have a reserve of area,
and that those in which the pericardium is housed
outside the stent were more efficient. The geometric
study results implied that geometrical characteristics
are not parameters that can reliably predict which
prosthesis will perform better than any other. The TRI
valve displayed the best fluid dynamic and geometric
behaviors, despite having the smallest ID.
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